Geode Capital Management, LLC Glycomimetics Inc Transaction History
Geode Capital Management, LLC
- $1.24 Trillion
- Q1 2025
A detailed history of Geode Capital Management, LLC transactions in Glycomimetics Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 571,726 shares of GLYC stock, worth $7.59 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
571,726
Previous 521,223
9.69%
Holding current value
$7.59 Million
Previous $130,000
7.69%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding GLYC
# of Institutions
38Shares Held
30.8MCall Options Held
80.9KPut Options Held
20.8K-
Bvf Inc San Francisco, CA9.54MShares$127 Million0.09% of portfolio
-
Logos Global Management LP San Francisco, CA5.4MShares$71.7 Million0.22% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.09MShares$67.6 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY3MShares$39.8 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$35.4 Million0.0% of portfolio
About GLYCOMIMETICS INC
- Ticker GLYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,423,900
- Market Cap $696M
- Description
- GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...